Davidson Trust Co. Sells 270 Shares of CVS Health Corporation $CVS

Davidson Trust Co. reduced its stake in CVS Health Corporation (NYSE:CVS) by 5.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 4,807 shares of the pharmacy operator’s stock after selling 270 shares during the quarter. Davidson Trust Co.’s holdings in CVS Health were worth $332,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of CVS. Goldman Sachs Group Inc. raised its holdings in CVS Health by 87.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 9,927,650 shares of the pharmacy operator’s stock worth $672,598,000 after purchasing an additional 4,632,530 shares during the period. Dodge & Cox increased its stake in CVS Health by 4.8% in the 1st quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator’s stock worth $4,976,856,000 after buying an additional 3,353,223 shares in the last quarter. Nuveen LLC purchased a new stake in CVS Health in the 1st quarter worth $204,421,000. Invesco Ltd. increased its stake in CVS Health by 13.2% in the 1st quarter. Invesco Ltd. now owns 20,413,853 shares of the pharmacy operator’s stock worth $1,383,039,000 after buying an additional 2,375,764 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. increased its stake in CVS Health by 815.2% in the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 2,663,111 shares of the pharmacy operator’s stock worth $183,701,000 after buying an additional 2,372,121 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

Analyst Ratings Changes

CVS has been the subject of a number of analyst reports. Wolfe Research increased their price target on CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a research note on Monday, September 22nd. Bernstein Bank cut their price target on CVS Health from $78.00 to $72.00 and set a “market perform” rating for the company in a research note on Wednesday, July 16th. Truist Financial set a $92.00 price target on CVS Health in a research note on Tuesday. Baird R W upgraded CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. Finally, Sanford C. Bernstein raised their price objective on CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a research report on Friday, September 5th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $81.05.

Insider Buying and Selling

In related news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the transaction, the director owned 22,156 shares in the company, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.22% of the company’s stock.

CVS Health Trading Up 1.6%

Shares of CVS Health stock opened at $79.67 on Wednesday. The firm has a market cap of $101.05 billion, a price-to-earnings ratio of 22.25, a PEG ratio of 0.87 and a beta of 0.60. The business has a 50-day moving average price of $72.95 and a 200-day moving average price of $67.83. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $79.94.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping the consensus estimate of $1.46 by $0.35. The company had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The firm’s revenue was up 8.4% on a year-over-year basis. During the same quarter last year, the business posted $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be given a $0.665 dividend. The ex-dividend date is Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.3%. CVS Health’s dividend payout ratio (DPR) is currently 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.